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Artificial shear stress effects on leukocytes at a biomaterial surface 
Radley G, Pieper IL, Thomas BR, Hawkins K, Thornton CA. 




Medical devices, such as ventricular assist devices (VADs), introduce both foreign 
materials and artificial shear stress to the circulatory system. The effects these have on 
leukocytes and the immune response are not well understood. Understanding how these 
two elements combine to affect leukocytes may reveal why some patients are susceptible 
to recurrent device-related infections and provide insight into the development of pump 
thrombosis.  
Biomaterials - DLC: diamond-like carbon coated stainless steel; Sap: single-crystal 
sapphire; and Ti: titanium alloy (Ti6Al4V) were attached to the parallel plates of a 
rheometer. Whole human blood was left between the two discs for 5 min at +37°C with 
or without the application of shear stress (0s-1 or 1000s-1). Blood was removed and used 
for: complete blood cell counts; flow cytometry (leukocyte activation; cell death; 
microparticle generation; phagocytic ability; and reactive oxygen species (ROS) 
production); and the production of pro-inflammatory cytokines.  
L-selectin expression on monocytes was decreased when blood was exposed to the 
biomaterials both with and without shear. Applying shear stress to blood on a Sap and Ti 
surface led to activation of neutrophils shown as decreased L-selectin expression. Sap and 
Ti blunted the LPS-stimulated macrophage migration inhibitory factor (MIF) production, 
most notably when sheared on Ti. 
The biomaterials used here have been shown to activate leukocytes in a static 
environment. The introduction of shear appears to exacerbate this activation. 
Interestingly, a widely accepted biocompatible material (Ti) utilised in many different 
types of devices, has the capacity for immune cell activation and inhibition of MIF 
secretion when combined with shear stress. These findings contribute to our 
understanding of the contribution of biomaterials and shear stress to recurrent infections 
and vulnerability to sepsis in some VAD patients as well as pump thrombosis. 
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The use of ventricular assist devices (VADs) as a therapy for end-stage heart failure 
patients ineligible for transplant has grown over recent decades (1, 2). There have been 
many improvements during this time with devices becoming smaller, their use more 
broadly acceptable, and with fewer device-related complications (3). Although the most 
recent device in clinical trials, HeartMate 3 (HM3, Abbott Laboratories, IL, USA), has 
successfully tackled pump thrombosis, other complications such as infection, ischaemic 
stroke, and gastrointestinal bleeding remain (4). Infection rates have been deemed 
lowered in second generation pumps with approximately 7% of HeartMate II (HMII; 
Abbott Laboratories) and HVAD (HeartWare Inc., Framingham, MA, USA) patients 
being affected (5, 6). However, recent data from HeartMate 3 patients has shown an 
increased rate of 22-36% (3, 7).  
VAD-related complications are thought to be the result of non-physiological shear stress 
patterns causing activation and damage of blood cells and proteins (8). Red blood cells 
(RBCs) can tolerate relatively high shear stress in comparison to other blood cell types 
with haemolysis occurring due to deformation and fragmentation around 200 – 300 Pa (9, 
10). Flow conditions within VADs disrupt natural haemodynamics through briefly 
exerting high shear stresses (10-800 Pa) on platelets (11, 12). Platelets exposed briefly to 
high shear stresses become sensitised to lower shear stress causing rapid activation of 
platelets and predisposition to thrombus formation (13). 
In comparison to RBCs and platelets, the effects of shear stress and VADs on leukocytes 
are largely overlooked but are equally important being linked to both infection and 
thrombus formation. In vitro studies using a concentric cylinder viscometer on whole 
human blood found a significant effect on white blood cell viability, count, and enzyme 
release at shear stresses of 10 – 60 Pa, much lower value than is critical for red blood cell 
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damage (14, 15). Leukocyte morphology and function also changes under shear stress. 
Isolated neutrophils seeded on cardiovascular device materials then exposed to shear 
stresses above 0.6 Pa become compact, irregularly shaped, and incapable of interacting 
with bacteria (16). Another study using micropipettes to apply fluid stress identified an 
immediate retraction of neutrophil pseudopodia upon the application of a shear stress of 
~ 0.04 Pa and neutrophil granule velocity was enhanced significantly by shear stress (0.1 
Pa) (17). These observations suggest that shear stress has multiple effects on leukocytes 
including mediating water entry into the cell and the breakdown of F-actin (17) to cause 
cell swelling/lysis (14).  Such damaging effects serve to reduce the normal function of 
leukocytes to protect the body from invading pathogens through impaired phagocytic 
ability and decreased cell proliferation. 
Clinically, VAD implantation has been associated with a decline in peripheral blood 
leukocyte counts and an increase in activation marker macrophage antigen-1 (MAC-1) 
expression on granulocytes (18). Higher levels of apoptosis in CD4+ and CD8+ T cells 
and a defective proliferative response to pathogens have also been noted in VAD 
recipients (19-22) which could contribute to recurrent infections. A reduction in the 
expression of human leukocyte antigen-D related (HLA-DR) on monocytes has also been 
observed in VAD recipients and suggested to be a marker of mortality (23). VADs are 
associated with increased formation of microparticles from platelets, leukocytes, and 
endothelial cells (24). MPs are potentially related to VAD-related thrombosis and 
infection through their pro-thrombotic and pro-inflammatory characteristics (25). In vitro 
testing of the CentriMag centrifugal pump using bovine blood showed a significant 
increase in the number of leukocyte-derived microparticles (LMPs) with minimal impact 
on the levels of plasma free haemoglobin (26) which are generated by high shear stress 
(24, 27). Subtypes of LMPs that emerge in the CentriMag with ovine blood differ with 
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levels of shear applied to the blood (28) – evidence that the mechanism of shear-induced 
damage may not be identical in all leukocyte types.  
Another factor in VAD-complications are the choice of biomaterial. The biomaterial 
surface of such devices adsorb proteins onto the surface immediately upon contact with 
blood. Cell activation and adhesion by this matrix is dependent on composition and can 
lead to formation of a thrombus composed of platelets, fibrin, leukocytes, and red blood 
cells (29, 30). The biomaterials used here have been investigated previously by us (29) 
and showed monocyte activation. 
The aim here was to examine the combined effects of shear stress and VAD-relevant 
biomaterials on human blood leukocytes using our previously developed a whole blood 
model (29). Here, this model is developed further to enable the combined effects of shear 
stress and biomaterials to be studied using a rheometer. 
Materials and Methods 
Blood collection 
Peripheral blood was collected from healthy adult volunteers into lithium heparin (18 I.U. 
lithium heparin salt per mL; Vacutainer tubes; Greiner Bio-One, Stonehouse, UK). All 
blood samples were collected with informed written consent. This study was approved by 
Wales Research Ethics Committee 6 (13/WA/0190).  
Biomaterial discs 
Biomaterial discs were prepared for use and surface area and surface roughness were 
measured as per previous study (29). The order of roughness from highest to lowest was 





An ARG2 rheometer (TA Instruments, New Castle, DE, USA) was used to subject 
samples to a controlled shear stress. The rheometer was calibrated by measuring the 
instrument inertia, followed by the inertia and friction of the chosen top geometry, a 60 
mm aluminium parallel plate with attached biomaterial disc. Attachment of the 
biomaterial discs required heating the Peltier to +80°C and applying Crystal Bond 
Adhesive (Agar Scientific, Stanstead, UK) with a melting temperature of +66°C. One of 
the two biomaterial discs was laid onto the centre of the pre-heated and glue covered 
Peltier. The other disc was placed on top of the first, heat conduction permitted the 
application of glue and the top plate geometry was then lowered onto it. Adjustments 
were made so that the two discs were parallel with one another and then the Peltier 
temperature was brought down to +25°C. The top plate was lowered down within 1 cm 
of the bottom Peltier plate and ‘zero gap’ was established through automated normal force 
calibrations. A final calibration for rotational mapping was completed (standard, 2 
iterations). The temperature was increased to +37°C for the experiment. Calibration of 
the plate geometry with attached disc was performed between samples to ensure the 
rheometer was balanced and inducing the correct level of shear was performed as above.  
Shearing whole blood between parallel plates and biomaterials 
Using the TRIOS software (TA Instruments) a procedure was set up for the use of the 60 
mm parallel plate geometry with the environment set to +37°C. The gap between top 
geometry plate and bottom Peltier plate was set to 400 µm which would allow 
approximately 1.2 mL of blood to be pipetted onto the surface. The soak time was set to 
30 secs, the duration set to 300 secs, and the shear rate used was either 0 s-1 or 1000 s-1. 
The blood was added and then the top plate was brought down to the ‘loading gap’ ready 
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for initiation of the procedure. After shearing, as much blood as possible was removed 
from the surface yielding ~ 500 µL for analysis. Blood was left between the parallel 
biomaterials without shear to observe the effect of the biomaterial alone and pipetted into 
a tube after 5 min.  After cleaning, another 1.2 mL blood was sheared at 1000 s-1 to look 
at the effect both biomaterial and shear have in combination. This shear rate is 
representative of the wall shear rates found in regions of centrifugal VADs such as along 
the outer wall and areas of the secondary flow path (31).  
Haematology 
Total and subset cell counts were measured using an automated haematology analyser 
(CELL-DYN Ruby; Abbott Diagnostics, Berkshire, UK). Baseline sample descriptive 
statistics are available in Supplementary Table 1. 
Flow Cytometry 
Neutrophil and monocyte activation 
Whole blood (20 µL) was stained with 110 ng/µL CD15-VioGreen (clone VIMC6, IgM, 
Miltenyi Biotec Ltd., Surrey, UK); 500 ng/µL CD14-Pacific Blue (clone M5E2, IgG2a, 
BioLegend, London, UK); 25 ng/µL CD62L-PE (clone DREG-56, IgG1κ, eBioscience); 
and 100 ng/µL CD11b-APC (clone CBRMI/5, IgG1κ, eBioscience). Samples were 
vortexed and incubated on ice in the dark for 30 min. Red blood cells were lysed using 
600 µL EasyLyse (Dako). Samples were vortexed and incubated at room temperature in 
the dark for 15 min. Finally, 1 µL DRAQ7, final concentration of 20 µM (BioStatus, 
Leicester, UK), was added to detect dead cells (32).  Whole blood stimulated with 10 
ng/mL LPS for 4 h at +37oC, 5% CO2-in-air was used as a positive control and unstained 
samples were used for gating purposes. Blood exposed to 1% Triton-X 100 (Fisher 
Scientific) was used to determine DRAQ7 positive cell gates. AbC beads (Life 
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Technologies, Paisley, UK) were stained singly with each antibody and used for 
compensation. Within 2 hours of staining, samples were acquired on the Navios flow 
cytometer (Three lasers (violet: 405 nm, blue: 488 nm, red: 638 nm and the standard filter 
configuration as supplied by the manufacturers, Beckman Coulter) using linear forward 
scatter (FSC) versus side scatter (SSC) scale, flow rate set to high, and stop gate on 10,000 
CD15+ events which would allow for acquisition of approximately 10,000 total 
lymphocytes and 1,000 monocytes. Compensation and data analysis were performed 
using Kaluza 1.5a (Beckman Coulter). 
Leukocyte microparticles 
20 µl blood samples were stained with 0.2 µg CD45-PE, clone 1.11.32, mouse IgG1 
(Thermo Fisher Scientific, Gloucester, UK) for 30 min on ice in the dark. The red blood 
cells were lysed by adding 600 μl EasyLyse (1:20 with dH2O, DAKO, Alere, Cheshire, 
UK), followed by vortexing and 15 min incubation at room temperature in the dark. 
Necrotic cells were stained with 0.1 µg 7AAD solution (eBioscience, Hatfield, Ireland, 
UK) at room temperature in the dark for 15 min before 60 sec acquisition on the Navios 
flow cytometer (Beckman Coulter, High Wycombe, UK).  
Leukocytes were gated and displayed on a contour density dot plot with 7AAD against 
CD45-PE. The healthy cell gate was set on the CD45+ population with high SSC. Any 
events to the right of this border were considered 7AAD-positive necrotic leukocytes. 
Fragmented white blood cells (LMPs) still display CD45 but no longer contain DNA and 
because of their reduced size and complexity, and therefore lower side scatter, end up 





BioParticles E.Coli K-12 strain, fluorescein conjugate were reconstituted as per 
manufacturer’s instructions (Thermo Fisher). Whole blood (100 µL) was added to tubes 
and 10 µL BioParticles (diluted 1:10 with PBS) added. Samples were incubated in a 
shaking water bath at +37°C for 30 min. Phagocytosis was stopped through the addition 
of 2.5 µL 200 µM Cytochalasin D (Sigma Aldrich, Dorset, UK). Tubes were then placed 
on ice and 3 mL ice cold PBS added before being centrifuged (+4°C, 515 xg, 7 min). 
Supernatant was discarded, and the tubes washed in ice cold PBS again. Blood was 
stained with CD14-PB and CD15-VG as above. 3 mL FACS lyse (BD Bioscience) was 
added and samples vortexed vigorously to encourage full lysis of red blood cells. Samples 
were incubated for 15 min in the dark on ice then centrifuged. Surface fluorescence was 
quenched by washing in 1 mL ice-cold PBS with 12.5 µL 0.2 µm-filtered trypan blue 
(33). A final wash with ice-cold PBS was performed before fixing samples in 200 µL 
FACS fix (BD Bioscience). Acquisition on the Navios occurred within 48 hours.  
Reactive Oxygen Species assay 
Stock solution of ROS assay stain concentrate (eBioscience) was reconstituted in 40 µL 
of DMSO and stored in aliquots at -20°C. A 1X working solution was prepared by diluting 
the stain concentrate with ROS assay buffer (eBioscience). 100 µL of 1X ROS assay stain 
was added per 1 mL blood and incubated for 60 min at +37°C, 5% CO2. Blood stimulated 
for 60 min with PMA at a final concentration of 1 µM was used as a positive control. 
ROS assay stained blood was then sheared as above and 20 µL of sheared blood sample 
added to a tube for lysis of red blood cells using EasyLyse as before, and acquisition on 
the flow cytometer (Navios). The median fluorescence intensity of ROS was measured in 




Whole blood cultures 
To model the effect of materials and shear on the function of leukocytes through their 
response to pathogenic stimuli, whole blood cultures (50 µL blood/150 µL RPMI 1640 
containing 2 mM GlutaMax and 0.1 mM 2-mercaptoethanol; Life Technologies) were left 
unstimulated or stimulated with 10 ng/mL E. coli OIII:B4 lipopolysaccharide (Ultrapure 
LPS, Invivogen, Toulouse, France) in a U-bottomed 96-well plate. After 24 h incubation 
at +37°C, 5% CO2-in-air cell-free supernatants were harvested by centrifugation (+4°C, 
515 x g, 7 min). Supernatants were used for cytokine analysis. 
ELISA 
Cytokines of interest were identified on the Human Cytokine Proteome Profiler Array 
(R&D Systems) performed as per manufacturer’s instructions (data not shown). 
Cytokines chosen for further analysis were macrophage migration inhibitory factor (MIF) 
and interleukin-1 alpha (IL-1α) (DuoSet; R&D Systems, Minneapolis, MN, USA) which 
were measured using a specific ELISAs. 
Statistical analysis 
GraphPad Prism 7 (GraphPad Software Inc., La Jolla, CA, USA) was used for all 
statistical analysis. Absolute values were compared to baseline values for each donor to 
obtain a fold change. Results were tested for normality using the column statistics 
function and were non-parametric. A Friedman test was conducted to compare material 
effects (baseline vs no shear), shear effects (baseline vs shear at 1000 s-1), and the effects 






Erythrocyte counts were not affected by biomaterials or shear (Figure 2A). Blood sheared 
on Sap had a significantly lower leukocyte count than non-sheared (p = 0.0004; Figure 
2B) which translated to significantly lower neutrophil (p = 0.018; Figure 2C) and 
lymphocyte (p = 0.0004; Figure 2E) counts. The monocyte count was significantly lower 
in comparison to baseline when sheared on DLC, Sap, and Ti (p = 0.002, 0.025, and 
0.007. respectively; Figure 2D). The platelet count was lowered on DLC and Sap without 
shear (p = 0.045, and 0.0005, respectively) whereas the inclusion of shear exacerbated 
the low platelet counts on DLC, Sap, and Ti (p = 0.0002, 0.001, and 0.0014, respectively; 
Figure 2F). 
Leukocyte activation 
Given that total leukocyte and subset counts differed by exposure to shear and 
biomaterials, the activation status of neutrophils and monocytes was considered. L-
selectin expression by neutrophils decreased significantly in blood sheared on Sap and Ti 
compared to the baseline (p = 0.0007 and 0.0034, respectively; Figure 3A) whereas 
shearing on the Ti surface decreased expression compared to non-shear (p = 0.0076). 
Exposure to Sap without shear significantly increased CD11bBright expression on 
neutrophils (p = 0.039), but not with shear (Figure 3B). Significantly decreased L-selectin 
expression was a feature of monocytes exposed to all biomaterials both with and without 
shear (Figure 3D). Results from neutrophils and monocytes without shear were consistent 
with previous results exposing these biomaterials to blood in a static environment (34). 
CD11bBright expression on monocytes increased significantly in all samples apart from 
those in contact with DLC without shear (Figure 3E). Cell death was unchanged for both 




The blood from the rheometers was stained with CD45/7AAD to determine the effect of 
shear stress and biomaterials on their prevalence of leukocyte microparticles (LMPs).  
However, this was not the case as neither biomaterial nor shear affected the number of 
CD45+ putative LMPs (Figure 4). 
Phagocytosis 
Cell functionality was then considered, again with a focus on neutrophils and monocytes 
as the rapid response cells of the innate immune system.  
Phagocytic function was measured through adding fluorescent E. Coli BioParticles to 
blood that had been in contact with the biomaterials with/without shear. The BioParticles 
were incubated with the blood for 5 min to observe initial phagocytosis and 30 min to full 
phagocytosis. Monocytes and neutrophils were identified with CD14 and CD15 
antibodies respectively (Supplementary Figure 2). 
A significant difference in the phagocytic ability of neutrophils was observed at 5 min in 
the sheared DLC, Sap, and Pel samples compared to the baseline (p = 0.009, 0.045, and 
0.023, respectively; Figure 5Ai). There was no difference in neutrophil phagocytosis at 
30 min (Figure 5Aii). Monocyte phagocytosis was unaffected by biomaterial or shear at 
either 5 or 30 min (Figure 5Bi and Bii).  
ROS production 
ROS production was not evident for neutrophils or monocytes when sheared between the 
biomaterials although it could be detected in response to the positive control PMA (Figure 




There was no significant difference compared to baseline in any of the samples for IL-1α 
(n = 4; Figure 7Ai). There was a significant increase between the baseline stimulated with 
LPS and the Sap 0 s-1 (S0), Sap 1000 s-1  (S1000), and Ti 1000 s-1 (T1000) stimulated for 
MIF concentration (p = 0.011, 0.028, and 0.006, respectively; n = 7; Figure 7Bi). When 
compared as a fold change from the unstimulated samples, an attenuated response to LPS 
in the samples sheared on Ti (T1000) was observed for MIF (p = 0.019; Figure 7Bii) but 
not IL-1α from the same samples. 
Discussion 
Increasing our understanding of shear-dependent blood trauma is important to the 
development of safer VADs as high shear stresses within the pumps causes haemolysis 
(35), platelet activation (13), leukocyte damage (14), and degradation of vWF (36). Heart 
failure is an inflammatory disorder which greatly affects leukocyte responses and patient 
outcomes (37, 38), making leukocytes critical to the success of VAD therapy. In vitro 
testing of shear stress on different blood components can aid in the design of VADs 
especially if consideration of the impact of biomaterials in this setting can be 
incorporated. The simple model presented here enables testing of shear stress and 
biomaterials simultaneously on multiple blood cell types, allowing an insight into how 
these affect leukocytes and how this may contribute to complication rates in VAD 
patients.   
To study the effects of both shearing and VAD candidate biomaterials on leukocytes, a 
rheometer model was developed. By attaching biomaterial discs to a rheometer, it was 
possible to shear healthy human blood between relevant biomaterials: DLC, Sap, and Ti. 
The rheometer model incorporates large gaps and long residence times, however, using a 
shear rate of 1000 s-1 represents some regions of centrifugal VADs, mainly in the 
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secondary flow path (31). Whilst this level of shear is neither stagnant (< 50 -100 s-1) 
resulting in thrombosis (39) , nor significantly high enough to cause cell damage (> ~5000 
s-1 (40)), it is a mid-range level of shear that causes leukocyte activation which contributes 
to thrombus formation (41). Also, surface roughness of the discs was monitored (29) with 
order of roughness from highest to lowest of DLC > Ti > Sap.  
Five minutes was chosen as the rheometer application time for two main reasons: 1) it 
was adequate for the user to add the blood, set the rheometer up, run, and then remove 
the blood without excessive haste, and 2) it was deemed long enough that changes might 
occur but not too far removed from the typical VAD residence time.  
Cell counts were measured using a haematology analyser to identify changes that could 
indicate cellular activation and/or damage. A problematic study limitation here was the 
blood volume pipetted from the surface of the biomaterials was approximately 500 μL 
which had to be divided between numerous assays. Consequently, the decision was made 
to prioritise the other assays and use the remaining blood for the haematology analyser. 
The CELL-DYN Ruby haematology analyser requires a minimum sample volume of 150 
μL with anything lower than that potentially affecting the counts. Equally, the analyser 
uses electrical impedance to count cells and therefore can be affected by cellular 
aggregation causing a clump of cells to be identified as a single cell. For example, the 
pseudolymphocytosis observed in Figure 2E is likely a process error due to aggregated 
cells (platelet-platelet/platelet-leukocyte) being identified as lymphocytes (42). These 
process errors were taken into account when interpreting the data. 
There was no significant effect on erythrocyte counts compared to the baseline sample or 
biomaterials with or without shear, but leukocyte counts were affected. Total leukocyte 
counts were decreased when blood was sheared on a Sap surface and this was associated 
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with a decreased neutrophil and lymphocyte count. Monocyte counts were significantly 
decreased when sheared on DLC, Sap, and Ti. Platelet counts were significantly reduced 
on non-sheared Sap, and when sheared on DLC, Sap, and Ti. Decrease in platelet counts 
under shear has been noted previously as a sign of platelet activation (43, 44). This cell 
type was not studied further here but is the focus of ongoing work. Decreases in leukocyte 
counts under shear have been noted in the past in a model wherein whole blood was 
sheared for 10 min and there was a 25% decrease in leukocyte count at 60 Pa and 
membrane disruption at 15 Pa (14). This is not only a longer time but a higher shear stress 
than in our study (~ 10 Pa).  
There was also evidence of activation of neutrophils and monocytes measured as 
decreased L-selectin expression. L-selectin (CD62L) is shed from the surface of 
leukocytes when they are activated (45). Neutrophil expression of CD62L was decreased 
in the sheared Pel, Ti, and Sap blood and there was a significant decrease between non-
sheared and sheared blood on Ti. L-selectin on neutrophils is cleaved from the surface 
‘during rolling on a ligand-bearing surface under hydrodynamic shear flow’ according to 
Lee et al., and the mechanical shedding depends on the shear stress applied (46). Only 
neutrophils in contact with Sap with no shear increased CD11b expression. This may 
simply reflect the short duration of neutrophil shear exposure or that of the integrin 
subunit partners of CD11b, namely CD18, might have been a better measure. Fluid shear 
stress applied to whole blood on a glass surface significantly down-regulated neutrophil 
CD18 expression in comparison to non-sheared cells (47).  Monocytes also showed 
decreased CD62L in response to all biomaterials, as observed previously (29), and 
irrespective of the application of shear. Interestingly, CD11b expression was significantly 
increased in the sheared DLC monocytes likely relating to increased adhesion of 
monocytes as observed by Linder et al. (48) and in our previous studies with these 
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biomaterials (29). This also relates to the fact that macrophages adhere preferentially to 
rough surfaces under flow, as DLC had the highest surface roughness (49). The difference 
in the activation profile of the two leukocyte subtypes emphasises that they respond to 
certain conditions differently.  Biomaterials with or without shear did not have any effect 
on neutrophil and monocyte death nor on the generation of leukocyte microparticles 
(LMP).  
Given there was some effect on neutrophil and monocyte activation we then undertook a 
more detailed investigation of cell function by studying phagocytosis, ROS production 
and cytokine outputs in response to an inflammatory stimulus. Functional assays have 
been cited as ‘a more appropriate way to evaluate the effect of shear stress on leukocytes 
rather than simple cell counts’ (10). 
The host response to pathogens largely depends on the first defence provided by 
neutrophils which engulf pathogens via phagocytosis and the generation of ROS (50). 
Interestingly, neutrophils exposed to DLC, Pel, and Sap demonstrated a significantly 
reduced immediate phagocytic ability in comparison to baseline (5 min incubation). This 
appeared resolved when incubated for longer (30 min) with the E. Coli Bioparticles apart 
from in sheared Sap neutrophils which had lower, although again not significant, levels 
of phagocytosis. These possible alterations in phagocytic ability were not evident in the 
monocyte population. Diminished phagocytic ability has been noted in neutrophils 
adhered to cardiovascular device material subjected to physiological shear stresses for 60 
min (16). The effect of shear on ROS production focus largely on endothelial cells rather 
than leukocytes (51) and despite a robust ROS response to the positive control PMA, we 
could not detect ROS production in response to shear stress for any of the leukocyte 
subsets studied. Finally, cytokine response to a commonly used prototypic inflammatory 
stimuli – LPS - was considered (52). Instead of simply measuring the same cytokines as 
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previously (29) or used by other investigators (53-55), an array approach was used first 
to better identify candidates for further analysis. IL-1α is an IL-1 family member that 
interacts with the IL-1 receptor to produce a pro-inflammatory response (56). 
Biomaterials and shear did not alter the levels of IL-1α produced into the supernatant or 
the fold change of LPS-stimulated compared to baseline levels in the absence of 
stimulation. The difference in surface roughness of the materials did not appear to 
influence the production of IL-1α. Surface roughness has been shown to positively 
correlate with cytokine production (57), however this has been observed in surfaces above 
4 μm, far higher than that in this study. Macrophage migration inhibitory factor (MIF) is 
involved in cell-mediated immunity and is considered an inflammatory cytokine that 
regulates macrophage function (58). Macrophages release MIF upon stimulation with 
LPS (59) with high levels of MIF in circulation known to exacerbate sepsis (60). Here, 
the most notable effect on MIF is the complete abrogation of the LPS-stimulated MIF 
response after shearing on Ti. Why there should be such a dramatic effect on MIF when 
the IL-1a response is unaffected remains to be determined. Lack of MIF might contribute 
to an immunosuppression environment. Many pathogens, trauma, burns, and major 
surgery can cause acute immunosuppression leading to a diminished capability of 
responding to infection (61). The combination of major surgery and implantation of a 
VAD that is largely composed of titanium alloy could potentially increase patient 
susceptibility to infection. 
It is important to note that the trajectory of an individual leukocyte is variable throughout 
the pump: therefore residence time and exposure to shear stress will be variable. 
Biomaterial contact is limited in the primary flow path, but a small number of leukocytes 
will travel through the secondary flow path which is prone to smaller gaps, higher shear, 
and low volumetric flow rates (62). Activation and adhesion in this area would be more 
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apparent and influenced by a variety of factors including surface finish, device design, 
circulatory stasis, inflammatory profile, and anticoagulation. Leukocytes are the most 
complex blood cell types and understanding their response to shear stress will prove 
useful during VAD development.  
Conclusion 
Our previous work showed that Sap causes higher levels of leukocyte activation than the 
other biomaterials studied (29) and the rheometer model demonstrates that these are likely 
exacerbated by shearing. This could pose a problem for VAD developers as Sap is 
considered for VAD bearings, an area of very high shear and prone to thrombus 
generation. The finding here that titanium, which is used often for medical devices and 
implants, could cause a reduction in the normal cytokine response towards pathogenic 
stimuli could open new avenues of research into why infections occur in both VAD 
patients and those with titanium implants in general.  The rheometer model has its 
limitations, but it does allow the combined effects of shear and biomaterials to be 
evaluated on a small volume of blood making the assay possibilities vast. The small blood 
volume recovered (~ 500 µL) allows for complete blood cell counts, flow cytometry, and 
other whole blood approaches to be considered. This also lends use of the model to 
clinical scenarios such as adult and paediatric patients with heart failure or congenital 
anomalies who will most likely have different baseline leukocyte responses towards 





Removed for peer-review 
Conflict of interest 
Removed for peer-review 
Author contributions 




1. Lampropulos JF, Kim N, Wang Y, Desai MM, Barreto-Filho JAS, Dodson JA, et 
al. Trends in left ventricular assist device use and outcomes among Medicare 
beneficiaries, 2004–2011. Open Heart. 2014;1(1). 
2. Hunt SA. The REMATCH trial: Long-term use of a left ventricular assist device 
for end-stage heart failure. J Card Fail. 2002;8(2):59-60. 
3. Netuka I, Sood P, Pya Y, Zimpfer D, Krabatsch T, Garbade J, et al. Fully 
Magnetically Levitated Left Ventricular Assist System for Treating Advanced HF: A 
Multicenter Study. J Am Coll Cardiol. 2015;66(23):2579-89. 
4. Krabatsch T, Netuka I, Schmitto JD, Zimpfer D, Garbade J, Rao V, et al. 
Heartmate 3 fully magnetically levitated left ventricular assist device for the treatment of 
advanced heart failure –1 year results from the Ce mark trial. Journal of cardiothoracic 
surgery. 2017;12(1):23. 
5. Tsiouris A, Paone G, Nemeh HW, Borgi J, Williams CT, Lanfear DE, et al. Short 
and long term outcomes of 200 patients supported by continuous-flow left ventricular 
assist devices. World journal of cardiology. 2015;7(11):792-800. 
6. Lalonde SD, Alba AC, Rigobon A, Ross HJ, Delgado DH, Billia F, et al. Clinical 
differences between continuous flow ventricular assist devices: a comparison between 
HeartMate II and HeartWare HVAD. Journal of cardiac surgery. 2013;28(5):604-10. 
7. Hanke J, Dogan G, Zoch A, Ricklefs M, Wert L, Feldmann C, et al. One year 
outcomes with the HeartMate 3 left ventricular assist device. The Journal of Thoracic and 
Cardiovascular Surgery. 2018. 
8. Chan C, Pieper IL. Multispecies study - update when published! XXXX. 
9. De Somer F, Foubert L, Vanackere M, Dujardin D, Delanghe J, Van Nooten G. 
Impact of oxygenator design on hemolysis, shear stress, and white blood cell and platelet 
counts. J Cardiothorac Vasc Anesth. 1996;10(7):884-9. 
21 
 
10. Carter J, Hristova K, Harasaki H, Smith WA. Short exposure time sensitivity of 
white cells to shear stress. ASAIO journal (American Society for Artificial Internal 
Organs : 1992). 2003;49(6):687-91. 
11. Wurzinger LJ, Opitz R, Blasberg P, Schmid-Schonbein H. Platelet and 
coagulation parameters following millisecond exposure to laminar shear stress. 
Thrombosis and haemostasis. 1985;54(2):381-6. 
12. Kroll MH, Hellums JD, McIntire LV, Schafer AI, Moake JL. Platelets and shear 
stress. Blood. 1996;88(5):1525-41. 
13. Sheriff J, Bluestein D, Girdhar G, Jesty J. High-Shear Stress Sensitizes Platelets 
to Subsequent Low-Shear Conditions. Annals of Biomedical Engineering. 
2010;38(4):1442-50. 
14. Dewitz TS, Hung TC, Martin RR, McIntire LV. Mechanical trauma in leukocytes. 
J Lab Clin Med. 1977;90(4):728-36. 
15. Dewitz TS, McIntire LV, Martin RR, Sybers HD. Enzyme release and 
morphological changes in leukocytes induced by mechanical trauma. Blood cells. 
1979;5(3):499-512. 
16. Shive MS, Salloum ML, Anderson JM. Shear stress-induced apoptosis of adherent 
neutrophils: a mechanism for persistence of cardiovascular device infections. Proceedings 
of the National Academy of Sciences of the United States of America. 2000;97(12):6710-
5. 
17. Moazzam F, DeLano FA, Zweifach BW, Schmid-Schönbein GW. The leukocyte 
response to fluid stress. Proceedings of the National Academy of Sciences of the United 
States of America. 1997;94(10):5338-43. 
18. Woolley JR, Teuteberg JJ, Bermudez CA, Bhama JK, Lockard KL, Kormos RL, 
et al. Temporal Leukocyte Numbers and Granulocyte Activation in Pulsatile and Rotary 
Ventricular Assist Device Patients. Artif Organs. 2013. 
19. Ankersmit HJ, Edwards NM, Schuster M, John R, Kocher A, Rose EA, et al. 
Quantitative changes in T-cell populations after left ventricular assist device 
22 
 
implantation: relationship to T-cell apoptosis and soluble CD95. Circulation. 
1999;100(19 Suppl):II211-5. 
20. Ankersmit HJ, Tugulea S, Spanier T, Weinberg AD, Artrip JH, Burke EM, et al. 
Activation-induced T-cell death and immune dysfunction after implantation of left-
ventricular assist device. Lancet. 1999;354(9178):550-5. 
21. Kimball P, Flattery M, Kasirajan V. T-cell response to staphylococcal enterotoxin 
B is reduced among heart failure patients on ventricular device support. Transplantation 
proceedings. 2006;38(10):3695-6. 
22. Kimball PM, Flattery M, McDougan F, Kasirajan V. Cellular immunity impaired 
among patients on left ventricular assist device for 6 months. Ann Thorac Surg. 
2008;85(5):1656-61. 
23. Kirsch M, Boval B, Damy T, Ghendouz S, Vermes E, Loisance D, et al. 
Importance of monocyte deactivation in determining early outcome after ventricular 
assist device implantation. The International journal of artificial organs. 2012;35(3):169-
76. 
24. Diehl P, Aleker M, Helbing T, Sossong V, Beyersdorf F, Olschewski M, et al. 
Enhanced microparticles in ventricular assist device patients predict platelet, leukocyte 
and endothelial cell activation. Interactive cardiovascular and thoracic surgery. 
2010;11(2):133-7. 
25. Angelillo-Scherrer A. Leukocyte-derived microparticles in vascular homeostasis. 
Circulation Research. 2012;110(2):356-69. 
26. Chan CH, Pieper IL, Hambly R, Radley G, Jones A, Friedmann Y, et al. The 
CentriMag centrifugal blood pump as a benchmark for in vitro testing of 
hemocompatibility in implantable ventricular assist devices. Artif Organs. 
2015;39(2):93-101. 
27. Nascimbene A, Hernandez R, George JK, Parker A, Bergeron AL, Pradhan S, et 
al. Association between cell-derived microparticles and adverse events in patients with 
nonpulsatile left ventricular assist devices. J Heart Lung Transplant. 2014;33(5):470-7. 
23 
 
28. Pieper IL, Radley G, Christen A, Ali S, Bodger O, Thornton CA. Ovine Leukocyte 
Microparticles Generated by the CentriMag Ventricular Assist Device In Vitro. Artif 
Organs. 2018;42(6):E78-e89. 
29. Radley G, Pieper IL, Thornton CA. The effect of ventricular assist device-
associated biomaterials on human blood leukocytes. Journal of biomedical materials 
research Part B, Applied biomaterials. 2018;106(5):1730-8. 
30. Jaffer IH, Fredenburgh JC, Hirsh J, Weitz JI. Medical device-induced thrombosis: 
what causes it and how can we prevent it? Journal of Thrombosis and Haemostasis. 
2015;13:S72-S81. 
31. Jamiolkowski MA, Pedersen DD, Wu W-T, Antaki JF, Wagner WR. 
Visualization and Analysis of Biomaterial-centered Thrombus Formation within a 
Defined Crevice Under Flow. Biomaterials. 2016;96:72-83. 
32. Pieper IL, Radley G, Chan CHH, Friedmann Y, Foster G, Thornton CA. 
Quantification methods for human and large animal leukocytes using DNA dyes by flow 
cytometry. Cytometry Part A. 2016:565-74. 
33. Lowe DM, Bangani N, Mehta MR, Lang DM, Rossi AG, Wilkinson KA, et al. A 
novel assay of antimycobacterial activity and phagocytosis by human neutrophils. 
Tuberculosis (Edinburgh, Scotland). 2013;93(2):167-78. 
34. Radley G, Pieper IL, Thornton CA. The effect of ventricular assist device-
associated biomaterials on human blood leukocytes. Journal of Biomedical Materials 
Research Part B: Applied Biomaterials. 2017:n/a-n/a. 
35. Ding J, Niu S, Chen Z, Zhang T, Griffith BP, Wu ZJ. Shear-Induced Hemolysis: 
Species Differences. Artif Organs. 2015;39(9):795-802. 
36. Chan CH, Pieper IL, Fleming S, Friedmann Y, Foster G, Hawkins K, et al. The 
effect of shear stress on the size, structure, and function of human von Willebrand factor. 
Artif Organs. 2014;38(9):741-50. 
37. Caruso R, Botta L, Verde A, Milazzo F, Vecchi I, Trivella MG, et al. Relationship 
between pre-implant interleukin-6 levels, inflammatory response, and early outcome in 
24 
 
patients supported by left ventricular assist device: a prospective study. PloS one. 
2014;9(3):e90802. 
38. Masai T, Sawa Y, Ohtake S, Nishida T, Nishimura M, Fukushima N, et al. Hepatic 
dysfunction after left ventricular mechanical assist in patients with end-stage heart failure: 
role of inflammatory response and hepatic microcirculation. Ann Thorac Surg. 
2002;73(2):549-55. 
39. Hathcock JJ. Flow effects on coagulation and thrombosis. Arterioscler Thromb 
Vasc Biol. 2006;26(8):1729-37. 
40. Leverett LB, Hellums JD, Alfrey CP, Lynch EC. Red Blood Cell Damage by 
Shear Stress. Biophysical Journal. 1972;12(3):257-73. 
41. Swystun LL, Liaw PC. The role of leukocytes in thrombosis. Blood. 
2016;128(6):753. 
42. Brigden ML, Dalal BI. Cell Counter-Related Abnormalities. Laboratory 
Medicine. 1999;30(5):325 - 34. 
43. Bakir I, Hoylaerts MF, Kink T, Foubert L, Luyten P, Leunens V, et al. Mechanical 
stress activates platelets at a subhemolysis level: an in vitro study. Artif Organs. 
2007;31(4):316-23. 
44. Chan C, Pieper IL, Robinson CR, Friedmann Y, Kanamarlapudi V, Thornton CA. 
Shear Stress-Induced Total Blood Trauma in Multiple Species. Artificial Organs. 2017. 
45. Smalley DM, Ley K. L-selectin: mechanisms and physiological significance of 
ectodomain cleavage. Journal of cellular and molecular medicine. 2005;9(2):255-66. 
46. Lee D, Schultz JB, Knauf PA, King MR. Mechanical shedding of L-selectin from 
the neutrophil surface during rolling on sialyl Lewis x under flow. The Journal of 
biological chemistry. 2007;282(7):4812-20. 
47. Fukuda S, Schmid-Schonbein GW. Regulation of CD18 expression on neutrophils 
in response to fluid shear stress. Proceedings of the National Academy of Sciences of the 
United States of America. 2003;100(23):13152-7. 
25 
 
48. Linder S, Pinkowski W, Aepfelbacher M. Adhesion, cytoskeletal architecture and 
activation status of primary human macrophages on a diamond-like carbon coated 
surface. Biomaterials. 2002;23(3):767-73. 
49. Rich A, Harris AK. Anomalous preferences of cultured macrophages for 
hydrophobic and roughened substrata. Journal of cell science. 1981;50:1-7. 
50. Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and 
inflammation. Nature reviews Immunology. 2013;13(3):159-75. 
51. Cunningham KS, Gotlieb AI. The role of shear stress in the pathogenesis of 
atherosclerosis. Laboratory investigation; a journal of technical methods and pathology. 
2004;85(1):9-23. 
52. Damsgaard CT, Lauritzen L, Calder PC, Kjær TMR, Frøkiær H. Whole-blood 
culture is a valid low-cost method to measure monocytic cytokines — A comparison of 
cytokine production in cultures of human whole-blood, mononuclear cells and 
monocytes. Journal of immunological methods. 2009;340(2):95-101. 
53. Suska F, Esposito M, Gretzer C, Kalltorp M, Tengvall P, Thomsen P. IL-1alpha, 
IL-1beta and TNF-alpha secretion during in vivo/ex vivo cellular interactions with 
titanium and copper. Biomaterials. 2003;24(3):461-8. 
54. Brodbeck WG, Voskerician G, Ziats NP, Nakayama Y, Matsuda T, Anderson JM. 
In vivo leukocyte cytokine mRNA responses to biomaterials are dependent on surface 
chemistry. Journal of biomedical materials research Part A. 2003;64(2):320-9. 
55. Cohen HC, Joyce EJ, Kao WJ. Biomaterials selectively modulate interactions 
between human blood-derived polymorphonuclear leukocytes and monocytes. The 
American journal of pathology. 2013;182(6):2180-90. 
56. Bujak M, Frangogiannis NG. The role of IL-1 in the pathogenesis of heart disease. 
Archivum immunologiae et therapiae experimentalis. 2009;57(3):165-76. 
57. Refai AK, Textor M, Brunette DM, Waterfield JD. Effect of titanium surface 
topography on macrophage activation and secretion of proinflammatory cytokines and 
chemokines. Journal of biomedical materials research Part A. 2004;70(2):194-205. 
26 
 
58. Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of 
innate immunity. Nature reviews Immunology. 2003;3(10):791-800. 
59. Calandra T, Bernhagen J, Mitchell RA, Bucala R. The macrophage is an important 
and previously unrecognized source of macrophage migration inhibitory factor. The 
Journal of experimental medicine. 1994;179(6):1895-902. 
60. Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W, et al. 
MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature. 
1993;365(6448):756-9. 
61. Janeway CA, Travers P, Walport M, Shlomchik MJ. Failures of Host Defense 
Mechanisms.  Janeway's Immunobiology. 7th ed. New York, USA: Garland Science; 
2001. 
62. Zhang J, Gellman B, Koert A, Dasse KA, Gilbert RJ, Griffith BP, et al. 
Computational and experimental evaluation of the fluid dynamics and hemocompatibility 






Figure 1: Rheometer model. A & B) Biomaterial discs (Ti here) were attached in parallel 
to the geometry (bottom plate) and Peltier (top plate) using crystal bond adhesive. Blood 
was sandwiched between the biomaterial discs for 5 min at +37°C with/without shear (0 
s-1 /1000 s-1). Sample was pipetted from the surface after elapsed time (C). 
Figure 2: Complete cell counts before and after shear on biomaterials. Human whole 
blood was placed between biomaterial discs attached onto a rheometer.  Shear (1000 s-1) 
or no shear (0 s-1) was applied for 5 min. Samples were then measured on the clinical 
haematology analyser (mean ± SD; n = 7; significant decrease compared with baseline 
indicated with ‘*’; significance of applying shear to materials indicated with ‘$’). 
Figure 3: Leukocyte activation and death before and after shear on different 
biomaterials. Human whole blood was placed between biomaterial discs - diamond-like 
carbon coated stainless steel (DLC), single-crystal sapphire (Sap), and titanium alloy (Ti) 
-  attached onto a rheometer.  Shear (1000 s-1) or no shear (0 s-1) was applied for 5 min. 
Leukocyte activation was investigated by: A) Change in median fluorescent intensity 
(MFI) of CD62L on A) CD15+ neutrophils and D) CD14+ monocytes; Change in 
percentage of CD11bBright cells on B) CD15+ neutrophils and E) CD14+ monocytes. 
Percentage of C) CD15+ neutrophils and F) CD14+ monocytes cells are dead as 
determined by DRAQ7. All were compared to the time 0 baseline as a fold change 
(dashed line). The LPS positive control is indicated with a dotted line (mean ± SD, n = 9; 
significance compared with baseline indicated with ‘*’; significance of applying shear to 
materials indicated with ‘$’). 
Figure 4: Leukocyte microparticle generation before and after shear on different 
biomaterials. Human whole blood was placed between biomaterial discs- diamond-like 
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carbon coated stainless steel (DLC), single-crystal sapphire (Sap), and titanium alloy (Ti) 
-   attached onto a rheometer.  Shear (1000 s-1) or no shear (0 s-1) was applied for 5 min 
(mean ± SD; n = 3). The blood was stained with CD45 and 7AAD before acquiring on 
the flow cytometer. The number of CD45+ putative LMPs was compared as a fold change 
to the baseline sample.  
Figure 5: Phagocytic ability of neutrophils and monocytes before and after shear on 
different biomaterials. Human whole blood was placed between biomaterial discs - 
diamond-like carbon coated stainless steel (DLC), single-crystal sapphire (Sap), and 
titanium alloy (Ti) -   attached onto a rheometer.  Shear (1000 s-1) or no shear (0 s-1) was 
applied for 5 min. Samples were added to tubes and incubated in a +37°C shaking water-
bath with fluorescent E.coli bioparticles for 5 min and 30 min. Phagocytosis was 
compared to the baseline sample and measured as neutrophils (CD15+) or monocytes 
(CD14+) that were in the E. coliBright region at 5 minutes (Ai and Bi, respectively) and 30 
minutes and compared to the baseline sample (Aii and Bii, respectively) (mean ± SD, n 
= 6; significance compared with baseline indicated with ‘*’) 
Figure 6: ROS production before and after shear on different biomaterials. Blood 
was incubated at +37°C for 1 h with 1X ROS assay stain before being placed between 
biomaterial discs- diamond-like carbon coated stainless steel (DLC), single-crystal 
sapphire (Sap), and titanium alloy (Ti) - attached onto a rheometer.  Shear (1000 s-1) or 
no shear (0 s-1) was applied for 5 min (n = 3). Baseline blood stimulated with 1 µM PMA 
was used as a positive control. A) Overlay dot-plot for controls with and without ROS 
stain, B) Overlay histogram for controls with and without ROS stain. ROS production in 




Figure 7: IL-1α and MIF expression before and after shear on different 
biomaterials. Human whole blood was placed between biomaterial discs - diamond-like 
carbon coated stainless steel (DLC), single-crystal sapphire (Sap), and titanium alloy (Ti) 
- attached onto a rheometer.  Shear (1000 s-1) or no shear (0 s-1) was applied for 5 min. 
The samples were cultured with (stimulated – diagonal pattern) or without (unstimulated 
– chequered) 10 ng/mL LPS for 24 h at +37°C, 5% CO2. Supernatants were harvested 
and processed for Ai) IL-1α and Aii) as a fold change from the unstimulated sample (n = 
4) and Bi) MIF and Bii) as a fold change from the unstimulated sample (mean ± SD, n = 
7; * p ≤ 0.05, dashed line represents unstimulated sample) ELISA. 
Supplementary Figure 1: Gating strategy for leukocyte microparticles. Human blood 
stained with CD45-PE and 7AAD then acquired for 60 secs on the Navios flow cytometer. 
A) Forward-versus side-scatter plot (FSC/SSC), B) detection of CD45+ events on a CD45-
FITC versus side-scatter plot (CD45-FITC/SSC), C) CD45+ events were displayed on 
SSC vs 7AAD plot to display healthy, necrotic and leukocyte microparticles (CD45+ 
MPs).  
Supplementary Figure 2: Gating strategy for phagocytosis. Baseline blood was 
incubated in a +37°C shaking water-bath with fluorescent E. coli bioparticles for 5 min 
and 30 min. Phagocytosis was stopped through the addition of cytochalasin D and two 
washes with ice-cold PBS. Samples were stained with CD14 and CD15 antibodies, red 
blood cells were lysed, then samples were washed with ice cold PBS containing trypan 
blue to quench the bioparticles on the cell surface. E.coli bioparticles in PBS were used 
to gate the ‘Bright’ population indicating full phagocytosis. A) Forward-versus side-
scatter plot (FSC/SSC), B) detection of monocytes (CD14-PB/SSC), C) detection of 
neutrophils (CD15-VG/SSC), D) E. Coli BioParticles in PBS for gating purposes, E) 
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baseline CD15+ events phagocytosis after 5 min, E) baseline CD15+ events phagocytosis 
after 30 min. 
Supplementary Table 1: Baseline haematology descriptive statistics. Peripheral blood 
collected from healthy adult volunteers into lithium heparin anticoagulant was measured 
for complete cell count on the clinical haematology analyser. The minimum, 25th 
percentile, median, 75th percentile, maximum, mean, standard deviation, and standard 













































Supplementary Table 1 
 WBC NEU LYM MON RBC PLT 
Minimum 4.49 1.96 1.40 0.27 3.64 93 
25th 
percentile 
5.51 2.35 1.99 0.34 4.00 144 
Median 5.92 2.67 2.12 0.44 4.46 153 
75th 
percentile 
6.69 3.76 2.39 0.49 4.74 162 
Maximum 9.44 7.20 3.13 0.61 5.51 192 
Mean 6.35 3.48 2.20 0.43 4.46 149 
STD 1.71 1.97 0.57 0.12 0.67 36 
SEM 0.70 0.80 0.23 0.05 0.27 13 
Counts in 106/μL for RBC and 103/μL for all others. LYM: Lymphocytes; MON: 
Monocytes; NEU: Neutrophils; PLT: Platelet; RBC: Red Blood Cell; SEM: Standard 
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